Abstract
IN recent reports, Powell et al. described nonparathyroid humoral hypercalcemia in patients with neoplastic disease,1 and Tashjian and his colleagues have suggested the possible role of prostaglandins, or other unidentified substances, in cases of neoplastic disease as the cause of hypercalcemia not explained by bone metastases or detectable parathyroid hormone-like peptides.2 Hypercalcemia in mice bearing a prostaglandin-producing fibrosarcoma has been treated successfully by Tashjian and his co-workers2 with indomethacin, a potent inhibitor of prostaglandin synthesis.3 The following case adds support to the suggestion that some forms of hypercalcemia secondary to neoplastic disease are responsive to indomethacin, and may be due . . .
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
